Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 652

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Open access
Thuijs, Daniel J F M, Kappetein, A Pieter, Serruys, Patrick W, Mohr, Friedrich-Wilhelm, Morice, Marie-Claude, Mack, Michael J, Holmes, David R, Curzen, Nick, Davierwala, Piroze, Noack, Thilo, Milojevic, Milan, Dawkins, Keith D, da Costa, Bruno R, Jüni, Peter, Head, Stuart J, Casselman, Filip, de Bruyne, Bernard, Høj Christiansen, Evald, Ruiz-Nodar, Juan M., Vermeersch, Paul, Schultz, Werner, Sabaté, Manel, Guagliumi, Giulio, Grubitzsch, Herko, Stangl, Karl, Darremont, Olivier, Bentala, M., den Heijer, Peter, Preda, Istvan, Stoler, Robert, Mack, Michael J., Szerafin, Tamás, Buckner, John K., Guber, Myles S., Verberkmoes, Niels, Akca, Ferdi, Feldman, Ted, Beyersdorf, Friedhelm, Drieghe, Benny, Oldroyd, Keith, Berg, Geoff, Jeppsson, Anders, Barber, Kimberly, Wolschleger, Kevin, Heiser, John, van der Harst, Pim, Mariani, Massimo A., Reichenspurner, Hermann, Stark, Christoffer, Laine, Mika, Ho, Paul C., Chen, John C., Zelman, Richard, Horwitz, Phillip A., Bochenek, Andrzej, Krauze, Agata, Grothusen, Christina, Dudek, Dariusz, Heyrich, George, Davierwala, Piroze, Noack, Thilo, Kolh, Philippe, LeGrand, Victor, Coelho, Pedro, Ensminger, Stephan, Nasseri, Boris, Ingemansson, Richard, Olivecrona, Goran, Escaned, Javier, Guera, Reddy, Berti, Sergio, Morice, Marie-Claude, Chieffo, Alaide, Burke, Nicholas, Mooney, Michael, Spolaor, Alvise, Hagl, Christian, Näbauer, Michael, Suttorp, Maarten Jan, Stine, Ronald A., McGarry, Thomas, Lucas, Scott, Endresen, Knut, Taussig, Andrew, Accola, Kevin, Canosi, Umberto, Horvath, Ivan, Cannon, Louis, Talbott, John D., Akins, Chris W., Kramer, Robert, Aschermann, Michael, Killinger, William, Narbute, Inga, Holmes, David R., Burzotta, Francesco, Bogers, Ad, Zijlstra, Felix, Eltchaninoff, Helene, Berland, Jacques, Stefanini, Giulio, Cruz Gonzalez, Ignacio, Hoppe, Uta, Kiesz, Stefan, Gora, Bartlomiej, Ahlsson, Anders, Corbascio, Matthias, Bilfinger, Thomas, Carrie, Didier, Tchétché, Didier, Hauptman, Karl-Eugen, Stahle, Elisabeth, James, Stefan, Sandner, Sigrid, Laufer, Günther, Lang, Irene, Witkowski, Adam, Thourani, Vinod, Suryapranata, Harry, Redwood, Simon, Knight, Charles, MacCarthy, Philip, Curzen, Nick, de Belder, Adam, Banning, Adrian, Gershlick, Anthony · 2019 · The Lancet

Abstract

BACKGROUND The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention (PCI) using first-generation paclitaxel-eluting stents with coronary artery bypass grafting (CABG) in patients with de-novo three-vessel and left main coronary artery disease, and reported results up to 5 years. We now report 10-year all-cause death results. METHODS The SYNTAX Extended Survival (SYNTAXES) study is an investigator-driven extension of follow-up of a multicentre, randomised controlled trial done in 85 hospitals across 18 North American and European countries. Patients with de-novo three-vessel and left main coronary artery disease were randomly assigned (1:1) to the PCI group or CABG group. Patients with a history of PCI or CABG, acute myocardial infarction, or an indication for concomitant cardiac surgery were excluded. The primary endpoint of the SYNTAXES study was 10-year all-cause death, which was assessed according to the intention-to-treat principle. Prespecified subgroup analyses were performed according to the presence or absence of left main coronary artery disease and diabetes, and according to coronary complexity defined by core laboratory SYNTAX score tertiles. This study is registered with ClinicalTrials.gov, NCT03417050. FINDINGS From March, 2005, to April, 2007, 1800 patients were randomly assigned to the PCI (n=903) or CABG (n=897) group. Vital status information at 10 years was complete for 841 (93%) patients in the PCI group and 848 (95%) patients in the CABG group. At 10 years, 244 (27%) patients had died after PCI and 211 (24%) after CABG (hazard ratio 1·17 [95% CI 0·97-1·41], p=0·092). Among patients with three-vessel disease, 151 (28%) of 546 had died after PCI versus 113 (21%) of 549 after CABG (hazard ratio 1·41 [95% CI 1·10-1·80]), and among patients with left main coronary artery disease, 93 (26%) of 357 had died after PCI versus 98 (28%) of 348 after CABG (0·90 [0·68-1·20], pinteraction=0·019). There was no treatment-by-subgroup interaction with diabetes (pinteraction=0·66) and no linear trend across SYNTAX score tertiles (ptrend=0·30). INTERPRETATION At 10 years, no significant difference existed in all-cause death between PCI using first-generation paclitaxel-eluting stents and CABG. However, CABG provided a significant survival benefit in patients with three-vessel disease, but not in patients with left main coronary artery disease. FUNDING German Foundation of Heart Research (SYNTAXES study, 5-10-year follow-up) and Boston Scientific Corporation (SYNTAX study, 0-5-year follow-up).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(19)31997-x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 652

Metadata

Authors
Thuijs, D. J. F. M., Kappetein, A. P., Serruys, P. W., Mohr, F.-W., Morice, M.-C., Mack, M. J., Holmes, D. R., Curzen, N., Davierwala, P., Noack, T., Milojevic, M., Dawkins, K. D., da Costa, B. R., Jüni, P., Head, S. J., Casselman, F., de Bruyne, B., Høj Christiansen, E., Ruiz-Nodar, J. M., Vermeersch, P., Schultz, W., Sabaté, M., Guagliumi, G., Grubitzsch, H., Stangl, K., Darremont, O., Bentala, M., den Heijer, P., Preda, I., Stoler, R., Mack, M. J., Szerafin, T., Buckner, J. K., Guber, M. S., Verberkmoes, N., Akca, F., Feldman, T., Beyersdorf, F., Drieghe, B., Oldroyd, K., Berg, G., Jeppsson, A., Barber, K., Wolschleger, K., Heiser, J., van der Harst, P., Mariani, M. A., Reichenspurner, H., Stark, C., Laine, M., Ho, P. C., Chen, J. C., Zelman, R., Horwitz, P. A., Bochenek, A., Krauze, A., Grothusen, C., Dudek, D., Heyrich, G., Davierwala, P., Noack, T., Kolh, P., LeGrand, V., Coelho, P., Ensminger, S., Nasseri, B., Ingemansson, R., Olivecrona, G., Escaned, J., Guera, R., Berti, S., Morice, M.-C., Chieffo, A., Burke, N., Mooney, M., Spolaor, A., Hagl, C., Näbauer, M., Suttorp, M. J., Stine, R. A., McGarry, T., Lucas, S., Endresen, K., Taussig, A., Accola, K., Canosi, U., Horvath, I., Cannon, L., Talbott, J. D., Akins, C. W., Kramer, R., Aschermann, M., Killinger, W., Narbute, I., Holmes, D. R., Burzotta, F., Bogers, A., Zijlstra, F., Eltchaninoff, H., Berland, J., Stefanini, G., Cruz Gonzalez, I., Hoppe, U., Kiesz, S., Gora, B., Ahlsson, A., Corbascio, M., Bilfinger, T., Carrie, D., Tchétché, D., Hauptman, K.-E., Stahle, E., James, S., Sandner, S., Laufer, G., Lang, I., Witkowski, A., Thourani, V., Suryapranata, H., Redwood, S., Knight, C., MacCarthy, P., Curzen, N., de Belder, A., Banning, A., & Gershlick, A.
Venue
The Lancet
Publisher
Elsevier BV
Published
2019-10
Volume
394
Issue
10206
Pages
1325-1334
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2970357772
Cited by
652
References
33
FWCI
70.00
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. https://app.cochat.ai/papers/10.1016/s0140-6736(19)31997-x
The paper
Thuijs, D. J. F. M., Kappetein, A. P., Serruys, P. W., Mohr, F.-W., Morice, M.-C., Mack, M. J., Holmes, D. R., Curzen, N., Davierwala, P., Noack, T., Milojevic, M., Dawkins, K. D., da Costa, B. R., Jüni, P., Head, S. J., Casselman, F., de Bruyne, B., Høj Christiansen, E., Ruiz-Nodar, J. M., . . . Gershlick, A. (2019). Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. The Lancet. https://doi.org/10.1016/s0140-6736(19)31997-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.